Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave by Luigi Atripaldi, Silvia Sale, Mariaelena Capone, Vincenzo Montesarchio, Roberto Parrella, Gerardo Botti, Paolo Antonio Ascierto, Gabriele Madonna

Get full text

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma by Marco Tucci, Anna Passarelli, Francesco Mannavola, Luigia Stefania Stucci, Paolo Antonio Ascierto, Marilena Capone, Gabriele Madonna, Patrizia Lopalco, Francesco Silvestris

Get full text

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab by Silvana Morello, Mariaelena Capone, Claudia Sorrentino, Diana Giannarelli, Gabriele Madonna, Domenico Mallardo, Antonio M. Grimaldi, Aldo Pinto, Paolo Antonio Ascierto

Get full text

MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA by Rossella Salemi, Luca Falzone, Gabriele Madonna, Jerry Polesel, Diana Cinà, Domenico Mallardo, Paolo A. Ascierto, Massimo Libra, Massimo Libra, Saverio Candido, Saverio Candido

Get full text

Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents by Mariaelena Capone, Gabriele Madonna, Ester Simeone, Paolo A Ascierto, Antonio Sorrentino, Roberta Turiello, Elva Morretta, Maria Chiara Monti, Rosa Azzaro, Silvana Morello, Pasquale Del Gaudio

Get full text

1541 Stability of the gut microbiota during anti-pd1 immunotherapy defines complete response in melanoma patients by Massimo Barberis, Mariaelena Capone, Gabriele Madonna, Paolo A Ascierto, Luigi Buonaguro, Pier Ferrucci, Nicola Segata, Angeli DG Macandog, Carlotta Catozzi, Amir Nabinejad, Emilia Cocorocchio, Teresa Manzo, Luigi Nezi

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab by Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, Gabriele Madonna, Lucia Festino, Antonio Maria Grimaldi, Vito Vanella, Ester Simeone, Miriam Paone, Giuseppe Palmieri, Ernesta Cavalcanti, Corrado Caracò, Paolo Antonio Ascierto

Get full text

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Aut... by Ciro Francesco Ruggiero, Debora Malpicci, Luigi Fattore, Gabriele Madonna, Vito Vanella, Domenico Mallardo, Domenico Liguoro, Valentina Salvati, Mariaelena Capone, Barbara Bedogni, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto

Get full text

The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors by Domenico Liguoro, Rachele Frigerio, Arianna Ortolano, Andrea Sacconi, Mario Acunzo, Giulia Romano, Giovanni Nigita, Barbara Bellei, Gabriele Madonna, Mariaelena Capone, Paolo Antonio Ascierto, Rita Mancini, Gennaro Ciliberto, Luigi Fattore

Get full text

A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patient... by Mauro Cozzolino, Stefania Cocco, Michela Piezzo, Giovanna Celia, Susan Costantini, Valentina Abate, Francesca Capone, Daniela Barberio, Laura Girelli, Elisa Cavicchiolo, Paolo Antonio Ascierto, Gabriele Madonna, Alfredo Budillon, Michelino De Laurentiis

Get full text

Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients by Maria Luigia Carbone, Gabriele Madonna, Alessia Capone, Marianna Bove, Simona Mastroeni, Lauretta Levati, Mariaelena Capone, Paolo Antonio Ascierto, Federica De Galitiis, Stefania D’Atri, Cristina Fortes, Elisabetta Volpe, Cristina Maria Failla

Get full text

Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients by Domenico Galati, Serena Zanotta, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Marilena Romanelli, Ester Simeone, Lucia Festino, Francesca Sparano, Rosa Azzaro, Rosaria De Filippi, Antonio Pinto, Chrystal M. Paulos, Paolo A. Ascierto

Get full text

New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer by Susan Costantini, Gabriele Madonna, Elena Di Gennaro, Francesca Capone, Palmina Bagnara, Mariaelena Capone, Silvia Sale, Carmine Nicastro, Lidia Atripaldi, Giuseppe Fiorentino, Roberto Parrella, Vincenzo Montesarchio, Luigi Atripaldi, Paolo A. Ascierto, Alfredo Budillon

Get full text

308 Transcriptomic analysis of melanoma patients in adjuvant setting treated with anti PD1 therapy: real life study by Nicola Normanno, Andrew White, Mariaelena Capone, Gabriele Madonna, Corrado Caracò, Ester Simeone, Lucia Festino, Sarah Warren, Domenico Mallardo, Vito Vanella, Paolo Ascierto, Claudia Trojaniello, Maria Grazia Vitale, Antonio Sorrentino, Grazia D’Angelo, Marilena Tuffanelli

The Ratio of GrzB⁺ − FoxP3⁺ over CD3⁺ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma by Giosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, Annabella Di Mauro, Monica Cantile, Margherita Cerrone, Gabriele Madonna, Antonio Maria Grimaldi, Domenico Mallardo, Marco Palla, Sabrina Sarno, Anna Maria Anniciello, Maurizio Di Bonito, Paolo Antonio Ascierto, Gerardo Botti

Get full text

Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients by Mariaelena Capone, Federica Fratangelo, Diana Giannarelli, Claudia Sorrentino, Roberta Turiello, Serena Zanotta, Domenico Galati, Gabriele Madonna, Marilena Tuffanelli, Luigi Scarpato, Antonio M. Grimaldi, Assunta Esposito, Rosa Azzaro, Antonio Pinto, Ernesta Cavalcanti, Aldo Pinto, Silvana Morello, Paolo A. Ascierto

Get full text

Ipilimumab and Stereotactic Radiosurgery with CyberKnife^® System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience by Valentina Borzillo, Rossella Di Franco, Diana Giannarelli, Fabrizio Cammarota, Esmeralda Scipilliti, Emma D'Ippolito, Angela Petito, Marcello Serra, Sara Falivene, Antonio M. Grimaldi, Ester Simeone, Lucia Festino, Vito Vanella, Claudia Trojaniello, Maria Grazia Vitale, Gabriele Madonna, Paolo A. Ascierto, Paolo Muto

Get full text

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation by Ester Simeone, Giosuè Scognamiglio, Mariaelena Capone, Diana Giannarelli, Antonio M. Grimaldi, Domenico Mallardo, Gabriele Madonna, Marcello Curvietto, Assunta Esposito, Fabio Sandomenico, Francesco Sabbatino, Nicholas L. Bayless, Sarah Warren, SuFey Ong, Gerardo Botti, Keith T. Flaherty, Soldano Ferrone, Paolo A. Ascierto

Get full text

Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma by Anna Barbato, Antonella Iuliano, Mariagrazia Volpe, Romina D’Alterio, Simona Brillante, Filomena Massa, Rossella De Cegli, Sabrina Carrella, Massimiliano Salati, Annapina Russo, Giulia Russo, Sara Riccardo, Davide Cacchiarelli, Mariaelena Capone, Gabriele Madonna, Paolo A. Ascierto, Brunella Franco, Alessia Indrieri, Pietro Carotenuto

Get full text

Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evide... by Gabriele Madonna, Giuseppe V. Masucci, Mariaelena Capone, Domenico Mallardo, Antonio Maria Grimaldi, Ester Simeone, Vito Vanella, Lucia Festino, Marco Palla, Luigi Scarpato, Marilena Tuffanelli, Grazia D'angelo, Lisa Villabona, Isabelle Krakowski, Hanna Eriksson, Felipe Simao, Rolf Lewensohn, Paolo Antonio Ascierto

Get full text